Hospira Healthcare Corporation v The Kennedy Institute of Rheumatology, 2016 FCA 215 (Infliximab*)
Justice Nadon, Justice Pelletier, Justice Rennie, Justice de Montigny and Justice Gleason - 2016-08-31
Read full decision. Summary prepared by Alan Macek:
In an appeal from a prothonotary decision relating to inventor examinations, a five-member panel of the Federal Court of Appeal held that the court “should abandon the Aqua-Gem standard and adopt the one set out in Housen” for appeals from discretionary decisions of prothonotaries. See full blog post.
Decision relates to:
- A-303-15 - HOSPIRA HEALTHCARE CORPORATION v. THE KENNEDY INSTITUTE OF RHEUMATOLOGY which is an appeal from 2016 FC 436 in T-396-13